tiprankstipranks
Annovis Bio Inc (ANVS)
NYSE:ANVS
US Market
ANVS
Annovis Bio
RESEARCH TOOLSreports
Want to see ANVS full AI Analyst Report?

Annovis Bio (ANVS) Stock News & Sentiment

737 Followers
Annovis Bio Prices Registered Direct Offering to Fund Trials
Premium
Company Announcements
Annovis Bio Prices Registered Direct Offering to Fund Trials
1M ago
8K
ANVS
Annovis Bio: Advancing Phase 3 Neurodegeneration Programs Create Attractive Risk‑Reward Supporting Buy Rating
Premium
Ratings
Annovis Bio: Advancing Phase 3 Neurodegeneration Programs Create Attractive Risk‑Reward Supporting Buy Rating
3M ago
ANVS
Annovis Bio Advances Alzheimer’s Phase 3 Trial After Safety Nod
Premium
Company Announcements
Annovis Bio Advances Alzheimer’s Phase 3 Trial After Safety Nod
3M ago
8K
ANVS
Annovis Bio Hosts Regulation FD Investor Information Webinar
Premium
Company Announcements
Annovis Bio Hosts Regulation FD Investor Information Webinar
4M ago
8K
ANVS
Annovis Bio Advances Long-Term Buntanetap Safety Study in Parkinson’s Disease
Premium
Company Announcements
Annovis Bio Advances Long-Term Buntanetap Safety Study in Parkinson’s Disease
5M ago
ANVS
Annovis Bio Receives Buy Rating Amid Promising Phase 3 Trial Results and Strategic FDA Discussions for Buntanetap
Premium
Ratings
Annovis Bio Receives Buy Rating Amid Promising Phase 3 Trial Results and Strategic FDA Discussions for Buntanetap
6M ago
ANVS
Annovis Bio’s Strategic Advances and Insider Confidence Drive Buy Rating Amid Promising Alzheimer’s Treatment Progress
Premium
Ratings
Annovis Bio’s Strategic Advances and Insider Confidence Drive Buy Rating Amid Promising Alzheimer’s Treatment Progress
6M ago
ANVS
More ANVS News >

ANVS News on the Web

Annovis Bio (ANVS) Q1 2026 Earnings: EPS N/A, Revenue N/A -- Is the Stock Overvalued? GF Score ...
GuruFocus News
Neutral
Canaccord Genuity Keeps Their Buy Rating on Annovis Bio (ANVS)
TipRanks News
Bullish
Annovis Bio Prices Registered Direct Offering to Fund Trials
TipRanks News
Neutral
Annovis Secures Broad Patent Coverage for Buntanetap in Addressing Infection-Linked Neurological Injury
Market Chameleon
Neutral
Top Insider Makes Bold Multi-Million Dollar Move Into Annovis Bio
TipRanks News
Bearish
Annovis Bio secures U.S. patent for buntanetap
TipRanks News
Bullish
Annovis Bio enters partnership with NeuroRPM
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: Warby Parker (WRBY) and Annovis Bio (ANVS)
TipRanks News
Bullish

News Score - Last 7 Days

Very Negative
ANVS
Sector Average
Media Buzz
This Week3 articles
Weekly Average0 articles
News Sentiment
This Week59%
Sector Average77%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ANVS’s Media Buzz Sentiment?
Currently, no data Available
What is ANVS’s weekly average amount of articles?
Currently, no data Available
What is ANVS’s News Sentiment?
59% of articles about ANVS were positive this week, compared to its sector average of 77%.
    Healthcare Stocks that are Trending in the News
    DOCSDoximity
    AVAHAveanna Healthcare Holdings
    GOSSGossamer Bio
    CGENCompugen
    RLAYRelay Therapeutics
    Showing the stocks with the most bullish news sentiment over the past week